Bryan Frantz
About Bryan Frantz
Bryan Frantz is the Worldwide Medical Lead for the Next Generation CTLA-4 Program at Bristol Myers Squibb, with over two decades of experience in various roles within the company.
Current Role at Bristol Myers Squibb
Bryan Frantz currently serves as the Worldwide Medical Lead for the Next Generation CTLA-4 Program at Bristol Myers Squibb. This role, based in Princeton, New Jersey, involves overseeing and guiding the medical strategy and operational execution of the CTLA-4 program, focused on advancing cancer immunotherapy.
Past Experience in Oncology Project Management
Bryan Frantz has extensive experience in oncology project management, having held multiple roles at Bristol Myers Squibb focused on cancer treatment and research. From 2009 to 2010, he served as Associate Director of Oncology Project Management in Plainsboro, NJ, and from 2016 to 2018, he was Associate Director of Regional Clinical Operations. His background demonstrates a solid expertise in managing complex oncological projects and driving research initiatives.
Tenure as Director of Colorectal Cancer Programs
Between 2018 and 2022, Bryan Frantz was the Director, Headquarter Medical Lead for Colorectal Cancer at Bristol Myers Squibb. During this period, he played a significant role in the development and management of colorectal cancer programs, contributing substantially to advancing research and treatment methodologies for this type of cancer.
Background in Protocol Management
Bryan Frantz has a strong background in protocol management, having served as Sr. Protocol Manager at Bristol Myers Squibb from 2005 to 2009. In this role, he was responsible for overseeing clinical trial protocols, ensuring precise execution, and maintaining compliance with regulatory and ethical standards.
Educational Background in Nursing
Bryan Frantz studied at Kutztown University of Pennsylvania, where he achieved a Bachelor of Science in Nursing (BSN). His education provided a solid foundation in medical science and patient care, which has been integral to his various roles in medical leadership and clinical operations throughout his career.